Apyx Medical Profit Margin

The latest profit margin for APYX is -14.8% as of June 2026. That compares with -33.81% in the prior-year period — up 56.2% year over year. That is below the Healthcare sector average of 14.34%. Investors often review this figure alongside Apyx Medical's historical trend and sector peers before judging valuation or financial health.

Over the past year, APYX's profit margin moved from -33.81% to -14.8% — a 56.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Apyx Medical's valuation or profitability profile.

Against Healthcare companies, APYX currently prints -14.8% for profit margin, while the sector average sits near 14.34%. That is roughly 203.2% below the sector mean. Large gaps often invite a closer look at Apyx Medical's growth, margins, and balance sheet.

Profit Margin shows how effectively Apyx Medical converts resources into returns. At -14.8%, APYX may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -33.81% in the prior-year period — up 56.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting APYX's profit margin (-14.8%), review year-over-year change from -33.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.